BCR signaling inhibitors: An overview of toxicities associated with ibrutinib and idelalisib in patients with chronic lymphocytic leukemia

L. Falchi, J. M. Baron, C. A. Orlikowski, A. Ferrajoli

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'BCR signaling inhibitors: An overview of toxicities associated with ibrutinib and idelalisib in patients with chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences